Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2025-06-16 00:00:00 ET · period of report 2025-06-12 · accession 0001819790-25-000094 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-16 | 2025-06-13 | TARS | CHAUDHURI BHASKAR | Dir | M - OptEx | — | +3,350 | 8,700 | +63% | — |
| DM | 2025-06-16 | 2025-06-12 | TARS | CHAUDHURI BHASKAR | Dir | A - Grant | $0.00 | +7,494 | 4,540 | New | $0 |
| D | 2025-06-16 | 2025-06-13 | TARS | CHAUDHURI BHASKAR | Dir | M - OptEx | $0.00 | -3,350 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-13 | M | A | 3,350 | — | 8,700 | D | — | — | (F1) The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. |
| 2 | Derivative | Restricted Stock Units | 2025-06-12 | A | A | 2,954 | $0.00 | 2,954 | D | — · — to — | 2,954 Common Stock | (F3) Each RSU represents a contingent right to receive one share of the Company's common stock. (F4) RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. |
| 3 | Derivative | Stock Option (right to buy) | 2025-06-12 | A | A | 4,540 | $0.00 | 4,540 | D | $40.95 · — to 2035-06-11 | 4,540 Common Stock | (F2) Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. |
| 4 | Derivative | Restricted Stock Units | 2025-06-13 | M | D | 3,350 | $0.00 | 0 | D | — · — to — | 3,350 Common Stock | (F3) Each RSU represents a contingent right to receive one share of the Company's common stock. (F5) RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. |